Phase 3 confirmatory, randomised 1:1 double-blind, placebo-controlled study evaluating the analgesic efficacy of capsaicin 8% patches in chronic coccygodynia. CAPSACOX Study.

2023-504644-34-00 Protocol RC22_0415 Therapeutic confirmatory (Phase III) Ongoing, recruiting

Start 8 Nov 2023 · Status Ongoing, recruiting · 1 EU/EEA countries · 6 sites · Protocol RC22_0415

Overview

Sponsor-declared trial summary

Phase Therapeutic confirmatory (Phase III)
Status Ongoing, recruiting
Participants planned 188
Countries 1
Sites 6

Subject with chronic coccygodynia

Key facts

Sponsor
Centre Hospitalier Universitaire De Nantes
Participant type
Patients
Age range
18-64 years, 65+ years
Gender
Male and Female
Therapeutic area
Diseases [C] - Pathological Conditions, Signs and Symptoms [C23]
Trial duration
8 Nov 2023 → ongoing
Decision date (initial)
2023-08-08
Transition trial
No
Low-intervention
No
Rare-disease indication
No
Vulnerable population
Yes

External identifiers

EU CT number
2023-504644-34-00
ClinicalTrials.gov
NCT06023706

Trial design

CTIS Part I — objectives, methods, condition coding

Conditions and MedDRA coding

Subject with chronic coccygodynia

VersionLevelCodeTermSystem organ class
21.0 LLT 10054095 Neuropathic pain 10029205

Sponsors and contacts

Sponsor organisations, regulatory contacts, third parties

Centre Hospitalier Universitaire De Nantes

Sponsor organisation
Centre Hospitalier Universitaire De Nantes
Address
5 Allee De L Ile Gloriette, Cs 69301 Cs 69301
City
Nantes Cedex 1
Postcode
44093
Country
France

Scientific contact point

Organisation
Centre Hospitalier Universitaire De Nantes
Contact name
LEVESQUE Amélie

Public contact point

Organisation
Centre Hospitalier Universitaire De Nantes
Contact name
LEVESQUE Amélie

Locations

1 EU/EEA country · 6 investigational sites

By country

CountryMS statusPlanned subjectsSites
France Ongoing, recruiting 188 6
Rest of world 0

Investigational sites

France

6 sites · Ongoing, recruiting
Departmental Hospital Vendee
Algology, Boulevard Stephane Moreau, 85925, La Roche Sur Yon Cedex 9
Gie Groupe Hospitalier Paris Saint-Joseph/Vinci
Algology, 185 Rue Raymond Losserand, 75674, Paris Cedex 14
Centre Hospitalier Universitaire De Nantes
Algology, 1 Place Alexis Ricordeau, 44000, Nantes
CHU De Rouen
Algology, 1 Rue De Germont, Bp 96031, Rouen Cedex
Centre Hospitalier Regional Et Universitaire De Brest
Algology, Boulevard Tanguy Prigent, 29609, Brest Cedex 2
L'Hopital Prive Du Confluent
Algology, 4 Rue Eric Tabarly, 44277, Nantes Cedex 2

Country notifications

Trial-start, recruitment-start, end and early-termination notifications submitted per Member State

Country Trial startTrial end Recruitment startRecruitment end Early termination
France 2023-11-08 2023-11-08

Application history

4 submissions — initial application plus substantial / non-substantial modifications

#TypeCodeSubmittedReference MSConclusionDecision date
1 INITIAL IN 2023-05-04 France Acceptable
2023-08-08
2023-08-08
2 SUBSTANTIAL MODIFICATION SM-1 2023-09-08 France Acceptable 2023-10-12
3 SUBSTANTIAL MODIFICATION SM-2 2023-10-19 France Acceptable 2023-11-14
4 SUBSTANTIAL MODIFICATION SM-3 2024-04-22 France Acceptable
2024-07-22
2024-07-25